Page 351 - Total War on PTSD Final

psychotherapy. Once approved, patients will not be able to take the MDMA home—they won’t be filling their prescriptions at their local pharmacy. Instead, MDMA will only be available through a doctor and only in supervised therapeutic settings from certified clinicians.
MAPS has been championing and fundraising for MDMA research for 32 years and we are seeing stronger and stronger evidence that MDMA-assisted psychotherapy may be an effective treatment for PTSD, and may be a promising alternative to currently available treatment for PTSD. We intend to continue to develop and work towards approval for the treatment as diligently as we can.
NOTE: FDA Agrees to Expanded Access Program for MDMA-Assisted Psychotherapy for PTSD: https://maps.org/news/media/8008-press-release-fda-agrees-to-expanded-access- program-for-mdma-assisted-psychotherapy-for-ptsd
351 of 837